HBM Healthcare Investments (Cayman) Ltd.

13D and 13G Filings

13D/G filings: 13D on 1 security, 13G on 8 securities
CIK: 0001232258
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Vicore Pharma Holding AB 13G VCRE · 92581R104	VCRE	92581R104	8.0%	22,505,819	13G	10/13/2026 Event 6/30/2026
Chemomab Therapeutics Ltd. 13D/A Amendment 1 CMMB · 16385C203	CMMB	16385C203	12.5%	80,971,680	13D/A Amendment 1	9/9/2026 Event 9/7/2026
Chemomab Therapeutics Ltd. 13D CMMB · 16385C203	CMMB	16385C203	12.5%	80,971,680	13D	7/16/2026 Event 7/9/2026
ALX Oncology Holdings Inc. 13G/A Amendment 2 ALXO · 00166B105	ALXO	00166B105	6.5%	8,590,692	13G/A Amendment 2	5/15/2026 Event 3/31/2026
IO Biotech, Inc. 13G/A Amendment 5 IOBTQ · 449778109	IOBTQ	449778109	3.3%	2,433,943	13G/A Amendment 5	4/6/2026 Event 4/2/2026
Y-mAbs Therapeutics, Inc. 13G/A Amendment 7 YMAB · 984241109	YMAB	984241109	0%	0	13G/A Amendment 7	11/14/2025 Event 9/30/2025
Upstream Bio, Inc. 13G/A Amendment 1 UPB · 91678A107	UPB	91678A107	4.1%	2,195,111	13G/A Amendment 1	11/14/2025 Event 9/30/2025
ArriVent BioPharma, Inc. 13G AVBP · 04272N102	AVBP	04272N102	5.4%	2,195,014	13G	10/15/2025 Event 10/8/2025
Immuneering Corp 13G IMRX · 45254E107	IMRX	45254E107	5.7%	3,646,304	13G	10/3/2025 Event 9/26/2025
ALX Oncology Holdings Inc. 13G/A Amendment 1 ALXO · 00166B105	ALXO	00166B105	8.4%	4,500,000	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Upstream Bio, Inc. 13G UPB · 91678A107	UPB	91678A107	5.1%	2,715,056	13G	2/13/2025 Event 12/31/2024
IO Biotech, Inc. 13G/A Amendment 4 IOBTQ · 449778109	IOBTQ	449778109	8.2%	5,523,439	13G/A Amendment 4	2/13/2025 Event 12/31/2023
Benitec Biopharma Inc. 13G/A Amendment 2 BNTC · 08205P209	BNTC	08205P209	4.5%	1,041,669	13G/A Amendment 2	2/13/2025 Event 12/31/2024
ALX Oncology Holdings Inc. 13G ALXO · 00166B105	ALXO	00166B105	6.5%	3,426,929	13G	12/27/2024 Event 12/18/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.